VERTEX PHARMACEUTICALS INC / MA Non-operating Income/Expense 2011-2026 | VRTX
Beta
What is VERTEX PHARMACEUTICALS INC / MA's current non-operating income/expense?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual non-operating income/expense for 2025 was $-7.7M, a 91.06% increase from 2024. VERTEX PHARMACEUTICALS INC / MA non-operating income/expense for the quarter ending March 31, 2026 was $0.
What was VERTEX PHARMACEUTICALS INC / MA's non-operating income/expense in 2024?
VERTEX PHARMACEUTICALS INC / MA annual non-operating income/expense for 2024 was $-86.1M, a 277.63% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's non-operating income/expense in 2023?
VERTEX PHARMACEUTICALS INC / MA annual non-operating income/expense for 2023 was $-22.8M, a 86.17% increase from 2022.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$296.6M
→
FY2025
$-7.7M
111213141516171819202122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-7.7M | +91.1% | 10-K |
| FY2024 | $-86.1M | -277.6% | 10-K |
| FY2023 | $-22.8M | +86.2% | 10-K |
| FY2022 | $-164.8M | -3463.3% | 10-K |
| FY2021 | $4.9M | -98.3% | 10-K |
| FY2020 | $296.6M | +54.3% | 10-K |
| FY2019 | $192.2M | +24429.1% | 10-K |
| FY2018 | $-790,000 | +99.0% | 10-K |
| FY2017 | $-81.4M | -2070.5% | 10-K |
| FY2016 | $4.1M | +161.5% | 10-K |
| FY2015 | $-6.7M | -122.1% | 10-K |
| FY2014 | $30.4M | +341.2% | 10-K |
| FY2013 | $6.9M | +2129.8% | 10-K |
| FY2012 | $309,000 | +102.0% | 10-K |
| FY2011 | $-15.7M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →